As we get deeper into flu season, a new type of the influenza virus has been identified, the Centers for Disease Control and ...

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

ANSWER: Both colds and influenza (the “flu”) are respiratory illnesses that are caused by viruses. Influenza is caused specifically by the influenza viruses, which come in two main types (A and B).

HealthDay News — A quadrivalent nucleoside-modified messenger RNA (modRNA) influenza vaccine is superior to a licensed inactivated quadrivalent influenza vaccine, according to a study published in the ...

Cell-based influenza vaccines were superior to egg-based vaccines across patient populations during a recent influenza season ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported.

In a recent review published in the journal Nature Reviews Immunology, researchers discussed the limitations of current influenza vaccines and the potential for future vaccines to induce both T-cell ...

Several companies, including GSK, Sanofi and CSL Seqirus are beginning to ship influenza vaccine for the upcoming season 2024/25 flu season. GSK has started shipping doses of its trivalent influenza ...

In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side ...

The vaccine has been approved by HSA for use in individuals aged 2 to 49 years. Read more at straitstimes.com. Read more at ...